CSL Invests $1.5 Billion in Illinois Plasma Therapy Manufacturing Expansion Global biopharmaceutical leader CSL (ASX:CSL; USOTC:CSLLY) is significantly expanding its manufacturing presence in the United States with a $1.5 billion …
Tag: